|
Elmar R. Burchardt M.D. Ph.D. joined Aastrom in July 2006 and was appointed Vice President Medical Affairs in September 2006. Dr. Burchardt brings over 14 years of experience in the areas of hematopoietic stem cell transplantation hematology and cardiology to Aastrom. Previously Dr. Burchardt worked for Miltenyi Biotec GmbH in Germany where he served as Medical Director responsible for the worldwide development and market introduction strategy of 10 new clinical cell therapy products and one of the most extensive cell therapy development programs in cardiac diseases. Prior to that time he served as Senior Research Group Leader at the Pharmaceutical Research Center of Bayer AG in Germany. Dr. Burchardt holds M.Sc. and Ph.D. degrees in Biochemistry as well as an M.D. from Hannover Medical School West Germany and is an Associate Professor of Clinical Pharmacology at the University of Witten Herdecke in Germany. | 